Tag: School of Medicine and Public Health

In essence, the Wisconsin Idea states that the university should improve people’s lives well beyond the classroom. And while many alumni, students, and faculty have taken this principle to heart, Robert Dempsey, professor and chair of the Department of Neurological Surgery at UW–Madison, really embodies it. The World Health Organization, in fact, recently named him… Read more »

Cancers are typically classified based on their tissue of origin, and that determines treatment plans. Although that practice is unlikely to end anytime soon, tumor classifications based on genetics are gaining traction and could lead to more effective, personalized treatments for patients. “In recent years, we have recognized that even within one organ type of… Read more »

They are one of the most influential federal agencies working in the U.S. healthcare industry—and they wanted to know what Dr. Amy Kind’s research had uncovered. So, naturally, she and her colleagues headed to the Centers for Medicare and Medicaid Services to present findings and answer questions.

UW-Madison’s medical physics program is one of the best in the country and has allowed the UWCCC to be at the forefront of combining expanding technology of imaging with innovative therapies for cancer.

Due to their innovative approach to targeting cancer cells without harming healthy tissue, Dr. Sondel and his team have been asked to join the pediatric oncology “Dream Team” by Stand Up to Cancer, the American Association for Cancer Research, and the St. Baldrick’s Foundation. Representing unique collaborations across multiple disciplines, this alliance of 7 research groups is the only pediatric cancer Dream Team in North America.

There are over 27 million people in the U.S. living with chronic kidney disease, but only about 5,000 nephrologists nationwide, placing limitations on the number of individual medical appointments that can be made.

Due to the overuse of antibiotics in humans and livestock, multi-drug resistant pathogens, or superbugs, are on the rise. Now medical teams are running out of antibiotics that work, and researchers are racing to find new treatments that are both effective and safe for use.